This implicates the existence of other, RBM3-independent, mechanisms involved in sensitivity or resistance to chemotherapy in pancreatic cancer, that may become of importance in some tumors with high RBM3 expression that do not respond to chemotherapy. Here, RBM3 is linked to familial pancreatic carcinoma.